课题基金 / 基金详情

Development of screening system for searching cellular differentiation-inducing agents by utlizing human salivary cancer cells

Development of screening system for searching cellular differentiation-inducing agents by utlizing human salivary cancer cells
开发利用人唾液癌细胞寻找细胞分化诱导剂的筛选系统
批准号:
05557084
负责人:
SATO Mitsunobu
金额:
$7.04万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

SATO Mitsunobu的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.Neuron-like cells (HSG-AZAll) with ample neurofilament bundles and endoplasmic reticulum as well as alpha-and beta-chain of tubulin were isolated from human salivary cancer cell line HSG treated with 5-azactidine. This HSG-AZAll cells were found to from neurites and express synaptophysin and neuron-specific enolase in response to dibutyryl cyclic AMP.This indicated that HSG-AZAll cells might be useful for searching cellular differentiation-inducing agents which work via cAMP signal transduction. 2.We have found that the treatment of HSG cells with 5-fluorodeoxyuridine monophosphate results in the differentiation into myoepithelial cells and induciton of apoptosis. 3.We have found that the cultivation of HSG-AZA3 cells with an acinar cell phenotype, which were induced by treatment of HSG cells with 5-azacytidine, in the presence of 3,4-dihydro-6-[3,4-dimethoxybenzoyl)-1-piperazinyl]-2 (1H) -quinolnone (vesnarinone) results in the differentiation into chondrocytes.In addition, it has b … More een found that the treatment of HSG-AZA3 cells with 22-oxa-1alpha, 25-dihydroxyvitamin D_3 causes the differentiation into osteoblasts. 4.We have found that the treatment of HSG cells with etoposide, an inhibitor of DNA topoisomerase II,results in the induction of cells with a smooth muscle cell phenotype, such as expression of alpha-smooth muscle actin and myofilaments, as well as in the induction of apoptosis. 5.When adenoid squamous carcinoma-forming cells (TYS) , derived from human minor salivary gland present in the oral cavity, was treated with 5-fluorouracil or vesnarinone, it has been found that the induction of apoptosis and differentiation into acinar cells occurs in the treated cells. 6.The treatment with 22-oxa-1alpha, 25 (OH) _2D_3 of HSG-AZA3 cells grown as xenografts in nude mice resulted in the marked growth inhibition of tumors, in which bone formation and bone remodeling were detected. 7.When TYS nude mouse tumors were treated with vesnarinone, significant suppression of tumor growth as well as differentiation into both keratinocytes and acinar cells were detected in the treated tumors. Less
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
東 雅之: "SV40 不死化正常ヒト唾液腺細胞における野生型P53の発現" 日本口腔科学会雑誌. 43. 580-589 (1994)
Masayuki Higashi:“野生型 P53 在 SV40 永生化正常人唾液腺细胞中的表达”日本口腔医学会杂志 43. 580-589 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hideo Yoshida: "Emergence of a smooth muscle cell phenotype and apoptosis by treatment with etoposide,an inhibitor of DNA topoisomerase II,in a neoplastic human salivary intercalated duct cell line" Cancer Journal. 6. 220-228 (1993)
Hideo Yoshida:“用依托泊苷(一种 DNA 拓扑异构酶 II 抑制剂)治疗肿瘤性人唾液闰管细胞系时出现平滑肌细胞表型和凋亡”《癌症杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
東雅之: "SV40不死化正常ヒト唾液腺細胞における野生型P53の発現" 日本口腔科学会雑誌. 43. 580-589 (1994)
Masayuki Azuma:“野生型 P53 在 SV40 永生化正常人唾液腺细胞中的表达”日本口腔医学会杂志 43. 580-589 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
佐藤光信: "唾液腺腫瘍の分化誘導療法" 癌と化学療法. 20. 1028-1036 (1993)
Mitsunobu Sato:“唾液腺肿瘤的分化诱导疗法”《癌症与化疗》20。1028-1036(1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
35
    Syntheses of apatite via Ca complexes of amino acids involved innon-collagen protein
    • 批准号:
      22550183
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2010
    • 负责人:
      SATO Mitsunobu
    • 依托单位:
    Toll-like receptor 4 signaling : Enhancement of therapeutic effect of anti-cancer drugs and radiation in oral Cancer
    • 批准号:
      14207090
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.28万
    • 财政年份:
      2002
    • 负责人:
      SATO Mitsunobu
    • 依托单位:
    Development of the therapy for oral cancer by transduction of iNOS gene in combination with radiotherapy
    • 批准号:
      12557176
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.66万
    • 财政年份:
      2000
    • 负责人:
      SATO Mitsunobu
    • 依托单位:
    Study on differentiation and apoptosis-inducing therapy for head and neck cancer by vesnarinone
    • 批准号:
      10307051
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $25.81万
    • 财政年份:
      1998
    • 负责人:
      SATO Mitsunobu
    • 依托单位: